Related Experiment Video
Updated: May 11, 2026

Nucleoside Triphosphates - From Synthesis to Biochemical Characterization
Published on: April 3, 2014
Exploring DNA-6MP interactions to develop a receptor with selective binding properties
Anna Sołdatowska1, Marcin Urbanowicz1, Magdalena Urbanowicz2
1Nalecz Institute of Biocybernetics and Biomedical Engineering, Polish Academy of Sciences, Ks. Trojdena 4 St., 02-109 Warsaw, Poland.
Researchers identified a specific DNA sequence that selectively binds 6-mercaptopurine (6MP), a key drug metabolite. This discovery advances DNA-based biosensors for personalized medicine and therapeutic drug monitoring.
Area of Science:
- Biochemistry
- Molecular Biology
- Analytical Chemistry
Background:
- 6-mercaptopurine (6MP) and azathioprine (Aza) are crucial immunosuppressive drugs.
- Accurate monitoring of 6MP levels is vital for personalized medicine and preventing toxicity.
- Development of selective and sensitive biosensors for 6MP is an ongoing challenge.
Purpose of the Study:
- To identify DNA sequences that can selectively bind 6-mercaptopurine (6MP) and its prodrug azathioprine (Aza).
- To characterize the binding interaction, mode, strength, and selectivity of DNA-thiopurine complexes.
- To explore the potential of DNA-based bioreceptors for biosensing applications.
Main Methods:
- UV-Vis spectroscopy and high-performance liquid chromatography (HPLC) were used to analyze interactions.
- Nuclear magnetic resonance (NMR) techniques, including DOSY, TOCSY, and NOESY, elucidated binding modes and affinities.
- HPLC was employed to confirm selectivity against potential interferents.
Main Results:
- The DNA sequence dsDNA GGCAGGACGGAG demonstrated selective binding to 6MP with an affinity constant of 2.52 × 10^3 M⁻¹.
- HPLC confirmed the DNA strand's selectivity towards natural metabolites and active pharmaceutical ingredients.
- NMR studies indicated a preference for guanine-rich sequences and revealed the rapid conversion of Aza to 6MP upon DNA contact.
Conclusions:
- DNA sequences can be engineered as selective bioreceptors for 6MP detection.
- The identified DNA sequence offers a promising platform for developing novel biosensors.
- This research supports advancements in therapeutic drug monitoring and personalized medicine for patients on Aza/6MP treatment.
More Related Videos
10:05Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC Crosslinking of Small Molecules to Isolate Chromatin
Published on: January 20, 2016
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
Related Concept Videos
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Cooperative Binding of Transcription Regulators
Labeling DNA Probes
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
Drug-Receptor Bonds
In...